- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Hyperinsulinemia may predict diabetes and metabolic syndrome early in young adults
Mumbai: Hyperinsulinaemia could be an early biomarker of metabolic disease and progression to metabolic syndrome and diabetes mellitus (DM), a recent study published in Frontiers in Clinical Diabetes and Healthcare has shown.
"Hyperinsulinaemia in the absence of impaired glucose tolerance and normal haemoglobin A1C (HbA1c) may provide a much earlier indicator for detecting the risk of metabolic disease and progression to metabolic syndrome and diabetes mellitus," the researchers wrote.
The researchers note that HbA1c would still be a preferred marker for prediabetes diagnosis for community screening. However, people at high risk, with central adiposity, obesity, a family history of diabetes, or symptomatic (PCOS, acanthosis nigricans) should be tested for insulin resistance and hyperinsulinemia.
Hyperinsulinemia in the absence of impaired glucose tolerance and normal HbA1c indicates prediabetes. Not many Indian studies have focused on hyperinsulinemia, specifically in young adults. Rama A. Vaidya, Kasturba Health Society- Medical Research Center, Mumbai, India, and colleagues aimed to determine whether hyperinsulinemia may be present despite HbA1c being normal in a cross–sectional study.
The study was conducted on young adults and adolescents aged 16-25 living in Mumbai, India. The participants attended various academic institutions and underwent screening as the first step of a clinical trial for studying the efficacy of almond intake in prediabetes.
The study revealed the following findings:
- Among 1313 young adults, 4.2% of the participants were found to be prediabetic (ADA criteria), and 19.7% of them had HbA1c levels between 5.7%-6.4%.
- Almost 30.5% had hyperinsulinemia despite normal blood glucose levels and normal HbA1c.
- Among 533 people with HbA1c<5.7, 10.5% of participants had fasting insulin>15 mIU/L, and a higher percentage (39.4%) had stimulated insulin above 80 mIU/L. These participants had higher mean anthropometric markers than those with normal fasting and stimulated insulin.
To identify prediabetic patients, the researchers measured fasting blood glucose, HbA1c, and two h- glucose-stimulated blood glucose. In the same set of people, they measured fasting insulin and 2- h glucose-stimulated insulin. They determined how many individuals had normal HbA1c, and those who were prediabetic were hyperinsulinemia.
"Our findings revealed that as per the ADA criteria for blood glucose, only 4.2% were prediabetic, whereas 19.9% had HbA1c values in the prediabetic range (5.7% - 6.4%)," the researchers wrote. "That almost one-fifth of the young adults were prediabetic highlights the need to pay attention to this issue."
"Hyperinsulinaemia in the absence of impaired glucose tolerance and normal HbA1c may provide a much earlier indicator of detection for risk of metabolic disease and progression to metabolic syndrome and diabetes," they concluded.
Reference:
Vaidya, R. A., Desai, S., Moitra, P., Salis, S., Agashe, S., Battalwar, R., Mehta, A., Madan, J., Kalita, S., Udipi, S. A., & Vaidya, A. B. (2023). Hyperinsulinemia: An early biomarker of metabolic dysfunction. Frontiers in Clinical Diabetes and Healthcare, 4. https://doi.org/10.3389/fcdhc.2023.1159664
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751